Diagnosis of acute cellular rejection and antibody-mediated rejection on lung transplant biopsies

A perspective from members of the pulmonary pathology society

Anja C. Roden, Dara L. Aisner, Timothy Craig Allen, Marie Christine Aubry, Roberto J. Barrios, Mary B. Beasley, Philip T. Cagle, Vera L. Capelozzi, Sanja Dacic, Yimin Ge, Lida P. Hariri, Sylvie Lantuejoul, Ross A. Miller, Mari Mino-Kenudson, Andre L. Moreira, Kirtee Raparia, Natasha Rekhtman, Lynette Sholl, Maxwell L. Smith, Ming S. Tsao & 3 others Marina Vivero, Yasushi Yatabe, Eunhee S. Yi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Context.-The diagnosis and grading of acute cellular and antibody-mediated rejection (AMR) in lung allograft biopsies is important because rejection can lead to acute graft dysfunction and/or failure and may contribute to chronic graft failure. While acute cellular rejection is well defined histologically, no reproducible specific features of AMR are currently identified. Therefore, a combination of clinical features, serology, histopathology, and immunologic findings is suggested for the diagnosis of AMR. Objective.-To describe the perspective of members of the Pulmonary Pathology Society (PPS) on the workup of lung allograft transbronchial biopsy and the diagnosis of acute cellular rejection and AMR in lung transplant. Data Sources.-Reports by the International Society for Heart and Lung Transplantation (ISHLT), experience of members of PPS who routinely review lung allograft biopsies, and search of literature database (PubMed). Conclusions.-Acute cellular rejection should be assessed and graded according to the 2007 working formulation of the ISHLT. As currently no specific features are known for AMR in lung allografts, the triple test (clinical allograft dysfunction, donor-specific antibodies, pathologic findings) should be used for its diagnosis. C4d staining might be performed when morphologic, clinical, and/or serologic features suggestive of AMR are identified.

Original languageEnglish (US)
Pages (from-to)437-444
Number of pages8
JournalArchives of Pathology and Laboratory Medicine
Volume141
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Pathology
Transplants
Biopsy
Allografts
Lung
Antibodies
Heart-Lung Transplantation
Information Storage and Retrieval
Serology
PubMed
Databases
Staining and Labeling

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Diagnosis of acute cellular rejection and antibody-mediated rejection on lung transplant biopsies : A perspective from members of the pulmonary pathology society. / Roden, Anja C.; Aisner, Dara L.; Allen, Timothy Craig; Aubry, Marie Christine; Barrios, Roberto J.; Beasley, Mary B.; Cagle, Philip T.; Capelozzi, Vera L.; Dacic, Sanja; Ge, Yimin; Hariri, Lida P.; Lantuejoul, Sylvie; Miller, Ross A.; Mino-Kenudson, Mari; Moreira, Andre L.; Raparia, Kirtee; Rekhtman, Natasha; Sholl, Lynette; Smith, Maxwell L.; Tsao, Ming S.; Vivero, Marina; Yatabe, Yasushi; Yi, Eunhee S.

In: Archives of Pathology and Laboratory Medicine, Vol. 141, No. 3, 01.03.2017, p. 437-444.

Research output: Contribution to journalArticle

Roden, AC, Aisner, DL, Allen, TC, Aubry, MC, Barrios, RJ, Beasley, MB, Cagle, PT, Capelozzi, VL, Dacic, S, Ge, Y, Hariri, LP, Lantuejoul, S, Miller, RA, Mino-Kenudson, M, Moreira, AL, Raparia, K, Rekhtman, N, Sholl, L, Smith, ML, Tsao, MS, Vivero, M, Yatabe, Y & Yi, ES 2017, 'Diagnosis of acute cellular rejection and antibody-mediated rejection on lung transplant biopsies: A perspective from members of the pulmonary pathology society', Archives of Pathology and Laboratory Medicine, vol. 141, no. 3, pp. 437-444. https://doi.org/10.5858/arpa.2016-0459-SA
Roden, Anja C. ; Aisner, Dara L. ; Allen, Timothy Craig ; Aubry, Marie Christine ; Barrios, Roberto J. ; Beasley, Mary B. ; Cagle, Philip T. ; Capelozzi, Vera L. ; Dacic, Sanja ; Ge, Yimin ; Hariri, Lida P. ; Lantuejoul, Sylvie ; Miller, Ross A. ; Mino-Kenudson, Mari ; Moreira, Andre L. ; Raparia, Kirtee ; Rekhtman, Natasha ; Sholl, Lynette ; Smith, Maxwell L. ; Tsao, Ming S. ; Vivero, Marina ; Yatabe, Yasushi ; Yi, Eunhee S. / Diagnosis of acute cellular rejection and antibody-mediated rejection on lung transplant biopsies : A perspective from members of the pulmonary pathology society. In: Archives of Pathology and Laboratory Medicine. 2017 ; Vol. 141, No. 3. pp. 437-444.
@article{1acfa4a994d9485eb776e63966b43092,
title = "Diagnosis of acute cellular rejection and antibody-mediated rejection on lung transplant biopsies: A perspective from members of the pulmonary pathology society",
abstract = "Context.-The diagnosis and grading of acute cellular and antibody-mediated rejection (AMR) in lung allograft biopsies is important because rejection can lead to acute graft dysfunction and/or failure and may contribute to chronic graft failure. While acute cellular rejection is well defined histologically, no reproducible specific features of AMR are currently identified. Therefore, a combination of clinical features, serology, histopathology, and immunologic findings is suggested for the diagnosis of AMR. Objective.-To describe the perspective of members of the Pulmonary Pathology Society (PPS) on the workup of lung allograft transbronchial biopsy and the diagnosis of acute cellular rejection and AMR in lung transplant. Data Sources.-Reports by the International Society for Heart and Lung Transplantation (ISHLT), experience of members of PPS who routinely review lung allograft biopsies, and search of literature database (PubMed). Conclusions.-Acute cellular rejection should be assessed and graded according to the 2007 working formulation of the ISHLT. As currently no specific features are known for AMR in lung allografts, the triple test (clinical allograft dysfunction, donor-specific antibodies, pathologic findings) should be used for its diagnosis. C4d staining might be performed when morphologic, clinical, and/or serologic features suggestive of AMR are identified.",
author = "Roden, {Anja C.} and Aisner, {Dara L.} and Allen, {Timothy Craig} and Aubry, {Marie Christine} and Barrios, {Roberto J.} and Beasley, {Mary B.} and Cagle, {Philip T.} and Capelozzi, {Vera L.} and Sanja Dacic and Yimin Ge and Hariri, {Lida P.} and Sylvie Lantuejoul and Miller, {Ross A.} and Mari Mino-Kenudson and Moreira, {Andre L.} and Kirtee Raparia and Natasha Rekhtman and Lynette Sholl and Smith, {Maxwell L.} and Tsao, {Ming S.} and Marina Vivero and Yasushi Yatabe and Yi, {Eunhee S.}",
year = "2017",
month = "3",
day = "1",
doi = "10.5858/arpa.2016-0459-SA",
language = "English (US)",
volume = "141",
pages = "437--444",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "3",

}

TY - JOUR

T1 - Diagnosis of acute cellular rejection and antibody-mediated rejection on lung transplant biopsies

T2 - A perspective from members of the pulmonary pathology society

AU - Roden, Anja C.

AU - Aisner, Dara L.

AU - Allen, Timothy Craig

AU - Aubry, Marie Christine

AU - Barrios, Roberto J.

AU - Beasley, Mary B.

AU - Cagle, Philip T.

AU - Capelozzi, Vera L.

AU - Dacic, Sanja

AU - Ge, Yimin

AU - Hariri, Lida P.

AU - Lantuejoul, Sylvie

AU - Miller, Ross A.

AU - Mino-Kenudson, Mari

AU - Moreira, Andre L.

AU - Raparia, Kirtee

AU - Rekhtman, Natasha

AU - Sholl, Lynette

AU - Smith, Maxwell L.

AU - Tsao, Ming S.

AU - Vivero, Marina

AU - Yatabe, Yasushi

AU - Yi, Eunhee S.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Context.-The diagnosis and grading of acute cellular and antibody-mediated rejection (AMR) in lung allograft biopsies is important because rejection can lead to acute graft dysfunction and/or failure and may contribute to chronic graft failure. While acute cellular rejection is well defined histologically, no reproducible specific features of AMR are currently identified. Therefore, a combination of clinical features, serology, histopathology, and immunologic findings is suggested for the diagnosis of AMR. Objective.-To describe the perspective of members of the Pulmonary Pathology Society (PPS) on the workup of lung allograft transbronchial biopsy and the diagnosis of acute cellular rejection and AMR in lung transplant. Data Sources.-Reports by the International Society for Heart and Lung Transplantation (ISHLT), experience of members of PPS who routinely review lung allograft biopsies, and search of literature database (PubMed). Conclusions.-Acute cellular rejection should be assessed and graded according to the 2007 working formulation of the ISHLT. As currently no specific features are known for AMR in lung allografts, the triple test (clinical allograft dysfunction, donor-specific antibodies, pathologic findings) should be used for its diagnosis. C4d staining might be performed when morphologic, clinical, and/or serologic features suggestive of AMR are identified.

AB - Context.-The diagnosis and grading of acute cellular and antibody-mediated rejection (AMR) in lung allograft biopsies is important because rejection can lead to acute graft dysfunction and/or failure and may contribute to chronic graft failure. While acute cellular rejection is well defined histologically, no reproducible specific features of AMR are currently identified. Therefore, a combination of clinical features, serology, histopathology, and immunologic findings is suggested for the diagnosis of AMR. Objective.-To describe the perspective of members of the Pulmonary Pathology Society (PPS) on the workup of lung allograft transbronchial biopsy and the diagnosis of acute cellular rejection and AMR in lung transplant. Data Sources.-Reports by the International Society for Heart and Lung Transplantation (ISHLT), experience of members of PPS who routinely review lung allograft biopsies, and search of literature database (PubMed). Conclusions.-Acute cellular rejection should be assessed and graded according to the 2007 working formulation of the ISHLT. As currently no specific features are known for AMR in lung allografts, the triple test (clinical allograft dysfunction, donor-specific antibodies, pathologic findings) should be used for its diagnosis. C4d staining might be performed when morphologic, clinical, and/or serologic features suggestive of AMR are identified.

UR - http://www.scopus.com/inward/record.url?scp=85014450705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014450705&partnerID=8YFLogxK

U2 - 10.5858/arpa.2016-0459-SA

DO - 10.5858/arpa.2016-0459-SA

M3 - Article

VL - 141

SP - 437

EP - 444

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 3

ER -